For this session of the Researcher Seminars, we will have the pleasure to learn more about the work of:
- Mickaël Ohanna (researcher, team 11) : "Deubiquitinating enzyme PSMD14 controls cell survival and drives sensitivity to MAPK pathway inhibitors through histone H2A ubiquitination in melanoma cells."
